David C Marek Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David C Marek.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David C Marek. David C Marek is an Executive VP- Consumer Svces in WebMD Health Corp. ($WBMD) and a Chief Commercial Officer in Axsome Therapeutics, Inc. ($AXSM) and an Principal Executive Officer in Myovant Sciences Ltd. ($MYOV).
Address: C/O WEBMD HEALTH CORP. 111 EIGHTH AVENUE NEW YORK 10011 NY
Companies in which David C Marek is an Insider
Axsome Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David C Marek: Chief Commercial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 19 2020
$AXSM Market Capitalization: $85.23M
$AXSM Previous Close: $4.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Myovant Sciences Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David C Marek: Principal Executive Officer
Holdings: 357,865 shares
Current Value: $3,818,420
Latest Transaction: Apr 19 2021
$MYOV Market Capitalization: $630.81M
$MYOV Previous Close: $10.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
WebMD Health Corp.
Industry: SERVICES-BUSINESS SERVICES, NEC [7389]
Position of David C Marek: Executive VP- Consumer Svces
Holdings: 10,000 shares
Current Value: $506,500
Latest Transaction: Sep 05 2012
$WBMD Market Capitalization: $1.90B
$WBMD Previous Close: $50.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of David C Marek
Sentiment: All, AXSM, MYOV, WBMD
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19 2021 | MYOV | Myovant Sciences L ... | Marek David C | Principal Executive ... | Option Exercise | A | 17.88 | 208,218 | 3,722,938 | 208,218 | |
| Apr 19 2021 | MYOV | Myovant Sciences L ... | Marek David C | Principal Executive ... | Grant | A | 0.00 | 134,789 | 0 | 357,865 | 223.1 K to 357.9 K (+60.42 %) |
| Jan 20 2021 | MYOV | Myovant Sciences L ... | Marek David C | Principal Executive ... | Option Exercise | A | 20.54 | 306,427 | 6,294,011 | 306,427 | |
| Jan 20 2021 | MYOV | Myovant Sciences L ... | Marek David C | Principal Executive ... | Grant | A | 0.00 | 223,076 | 0 | 223,076 | 0 to 223.1 K |
| Jan 20 2021 | MYOV | Myovant Sciences L ... | Marek David C | Principal Executive ... | Option Exercise | A | 20.54 | 306,427 | 6,294,011 | 306,427 | |
| Jan 20 2021 | MYOV | Myovant Sciences L ... | Marek David C | Principal Executive ... | Grant | A | 0.00 | 223,076 | 0 | 223,076 | 0 to 223.1 K |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | Marek David C | Chief Commercial Of ... | Option Exercise | A | 0.00 | 16,533 | 0 | 16,533 |